Clinical trial
Study of KN046 With Chemotherapy in First Line Advanced NSCLC
NCT04054531
Study timeline
Study start (actual)2019-09-04Date precision: day
Registry last updated2019-09-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancerunresolved
Interventions
KN046BIOLOGICAL
PaclitaxelDRUG · verified · RxNorm: paclitaxel
PemetrexedDRUG · verified · RxNorm: pemetrexed
CarboplatinDRUG · verified · RxNorm: carboplatin
Sponsors & collaborators
Jiangsu Alphamab Biopharmaceuticals Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04054531 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.